Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Preferred Shares (2016 - 2018)

Lisata Therapeutics (LSTA) has disclosed Preferred Shares for 9 consecutive years, with $100.0 as the latest value for Q3 2018.

  • For the quarter ending Q3 2018, Preferred Shares changed 0.0% year-over-year to $100.0, compared with a TTM value of $100.0 through Sep 2018, changed 0.0%, and an annual FY2016 reading of $100.0, changed 0.0% over the prior year.
  • Preferred Shares was $100.0 for Q3 2018 at Lisata Therapeutics, roughly flat from $100.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $100.0 in Q1 2014 and bottomed at $100.0 in Q1 2014.
  • Average Preferred Shares over 5 years is $100.0, with a median of $100.0 recorded in 2014.
  • Peak annual rise in Preferred Shares hit 0.0% in 2014, while the deepest fall reached 0.0% in 2014.
  • Year by year, Preferred Shares stood at $100.0 in 2014, then changed by 0.0% to $100.0 in 2015, then changed by 0.0% to $100.0 in 2016, then changed by 0.0% to $100.0 in 2017, then changed by 0.0% to $100.0 in 2018.
  • Business Quant data shows Preferred Shares for LSTA at $100.0 in Q3 2018, $100.0 in Q2 2018, and $100.0 in Q1 2018.